Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Breast Neoplasms (Phase 1)
Carcinoma, Hepatocellular (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 1/Phase 2)
Diffuse Intrinsic Pontine Glioma (Phase 1)
Drugs, Investigational (Phase 1/Phase 2)
Esophageal Neoplasms (Phase 1/Phase 2)
Glioma (Phase 1/Phase 2)
Leukemia, Myeloid (Phase 1/Phase 2)
Lung Neoplasms (Phase 1/Phase 2)
Lymphoma (Phase 1/Phase 2)
Melanoma (Phase 1/Phase 2)
Mesothelioma (Phase 1/Phase 2)
Multiple Myeloma (Phase 1/Phase 2)
Neoplasms (Phase 1/Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 1)
Neuroblastoma (Phase 2)
Osteosarcoma (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Rhabdomyosarcoma (Phase 1)
Sarcoma (Phase 1/Phase 2)
Sarcoma, Ewing (Phase 1/Phase 2)
Sarcoma, Synovial (Phase 1/Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue